In the United States, the POCT market is valued at USD 2.2 billion in 2025 and projected to reach USD 4.2 billion by 2035, ...

T-cell therapy has revolutionised the treatment of B-cell malignancies, offering durable responses for patients with relapsed or refractory disease. However, access globally remains limited due to ...

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...

POLYVANTIS says its PLEXIGLAS and EUROPLEX films provide optical precision, chemical resistance, and biocompatibility for ...

In a boost to India’s fight against tuberculosis, apex health research body ICMR has validated new indigenously developed ...

The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...